InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Eizen Joshua M. Director active across 1 company, notably AN2 Therapeutics, Inc.. Aggregated, 10 filings have been recorded. Split: 0 buy · 4 sells. Total volume traded: €52k. Activity tracked since 15 March 2024. The latest transaction was filed on 8 July 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations
Eizen Joshua M is a declarant linked to AN2 Therapeutics, Inc. on XNAS, with 6 filings in total. In the recent filings tracked, they span 2024-03-18 to 2025-02-28, with 0 EUR in buys and 12620 EUR in sells, and the modal transaction nature is Attriution.